Swedish Orphan Biovitrum AB's Hemophilia A Therapy Receives European Commission Orphan Drug Designation
9/23/2010 11:45:36 AM
More...
|
New Number of Shares and Votes in Swedish Orphan Biovitrum AB
8/31/2010 11:42:26 AM
More...
|
Swedish Orphan Biovitrum AB's Kineret(R) has Received Orphan Drug Designation in the USA
8/26/2010 8:59:43 AM
More...
|
Presentation of Biovitrum AB's Interim Report January - June, 2010
7/13/2010 2:06:49 PM
More...
|
Biogen Idec, Inc. (North Carolina) (BIIB) and Swedish Orphan Biovitrum AB Announce Decision to Advance Long- Lasting Hemophilia A Therapy into a Registrational Trial
7/9/2010 10:02:54 AM
More...
|
Swedish Orphan Biovitrum AB and Dongbao announce Commercial Alliance for the Chinese and European markets
7/6/2010 11:07:15 AM
More...
|
Change of Company Name for Biovitrum AB
6/21/2010 9:33:11 AM
More...
|
Swedish Orphan Biovitrum AB And Biomodels To Develop Assay For Mucositis Risk In Cancer Treatment
5/11/2010 1:42:51 PM
More...
|
Swedish Orphan Biovitrum AB Presents First Positive Kiobrina(R) Clinical Phase II Data
5/6/2010 11:11:50 AM
More...
|
Biovitrum AB: Interim Financial Report For The Period 1 January To 31 March, 2010
4/27/2010 10:54:20 AM
More...
|
|